Zavation Buys CoreLink to Boost Spine Portfolio

Zavation Medical Products, maker of spinal implant, interventional spine, and biologics products has acquired CoreLink, a spinal implant and instrumentation systems provider.
 
Zavation and CoreLink will keep operating under their respective brands. The combined business will be led by Zavation CEO Jeffrey Johnson, and CoreLink CEO Jay Bartling will become chairman of the board. The Stephens Group—of which CoreLink is a portfolio company—will retain a minority stake in the combined company. Financial terms weren’t disclosed.
 
CoreLink leverages in-house additive manufacturing techniques to launch its Mimetic Metal technology, and invested heavily in medical education that includes a Bioskills facility in St. Louis to meet evolving surgical needs.
 
Combining Zavation and CoreLink merges product portfolios across spine and interventional pain management, geographic footprints, and customer bases spanning in-patient and outpatient care delivery. The increased scale helps the combined company keep investing in innovative tech. It also provides surgeon and distributor partners more rapid product development.
 
Johnson commented to the press, “The combination of Zavation and CoreLink brings together two industry-leading businesses with shared values and customer-centric cultures. We remain dedicated to working with our distributor partners to deliver the highest quality spinal solutions for surgeons and patients across the country. I look forward to joining forces with Jay and the CoreLink team to amplify our strengths and leverage our combined resources to offer more life-changing spinal devices.”
 
Bartling remarked, “At CoreLink, we’ve solidified our reputation as an innovator of quality orthopedic and spinal devices that have improved the quality of life for countless patients. We are confident this milestone will allow us to continue executing on our mission, while further enhancing our capabilities to best serve our surgeon partners.”